RYTHM Inc.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
The CIN framework assigns Rayonier a Neutral rating at 52/100, with conviction of 1 out of 5. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Fundamentals leads the pillar table at 70, and is the main lever behind the Neutral conclusion. The offset comes from editorial at 30, which pulls the composite toward the middle of the band.
Under the hood, the data points sit as follows: reported revenue growth of 2369.5 percent year over year, an operating margin of -30.4 percent, a market cap near 46 million, a filing cadence of 1 regulator events in the trailing 90 days. Each of those figures ties back to a specific input in the pillar breakdown. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Rayonier slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.
The clearest catalyst is the next quarterly print. Fundamentals contribute 70 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.
- IR / PR agency
- Haus Comms
- IR email
- IR@RYTHMinc.com
- IR page
- Investor relations
- Headquarters
- 2220 HICKS ROAD, SUITE 210, ROLLING MEADOWS, IL, 60008
- Phone
- 855-420-0020
- CEO
- Benjamin Kovler (Interim CEO)
- CFO
- Brad Asher
- SEC CIK
- 1800637
- Website
- Company website
- Market cap
- $46.1M
- Enterprise value
- $94.1M
- Price to book
- 1.28
- Price to sales
- 1.54
- EV / EBITDA
- -1.73
- Revenue (TTM)
- $30.0M
- Gross profit (TTM)
- $20.5M
- EBITDA
- $-14.0M
- Operating margin
- -30.4%
- Profit margin
- -39.0%
- Rev growth YoY
- 2369.5%
- Return on equity
- -36.4%
- Return on assets
- -16.8%
- EPS (TTM)
- $-14.41
- Shares outstanding
- 2.1M
- Insider ownership
- 47.6%
- Institutional ownership
- 10.5%
- Beta
- 9.46
- Full-time employees
- 1
- GICS sector
- Consumer Defensive
- GICS industry
- Tobacco
- Annual report
- Latest 10-K
- Proxy statement
- Latest DEF 14A
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for RYTHM Inc. (RYM)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for RYTHM Inc. (RYM), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, micro-cap, insider selling. (1 bullish signal, 3 bearish signals.)
Latest price: $22.50 (+1.90%) on OTCMKTS.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for RYM are maintained by Cannabis Investor News and refreshed throughout the trading day.